Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Neurochemistry|March 29, 2013
WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microgliaCarina Halleskog, Gunnar SchulteCellular Signalling|December 26, 2012
Pertussis toxin-sensitive heterotrimeric G(αi/o) proteins mediate WNT/β-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3ACarina Halleskog, Gunnar SchulteMethods in Molecular Biology (Clifton, N.J.)|April 19, 2023
Use of Isothermal Microcalorimetry to Measure Cellular Heat Production in Thermogenic AdipocytesMuhammad Hamza Bokhari, Carina Halleskog, Irina Shabalina, et al.Glia|October 23, 2010
WNT signaling in activated microglia is proinflammatoryCarina Halleskog, Jan Mulder, Jenny Dahlström, et al.Journal of Neuroinflammation|June 1, 2012
Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformationCarina Halleskog, Jacomijn Petronella Dijksterhuis, Michaela Brita Christina Kilander, et al.Bioorganic & Medicinal Chemistry Letters|November 15, 2023
Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic aminesKrista Jaunsleine, Linda Supe, Jana Spura, et al.Communications Biology|September 22, 2021
Isothermal microcalorimetry measures UCP1-mediated thermogenesis in mature brite adipocytesMuhammad Hamza Bokhari, Carina Halleskog, Alice Åslund, et al.Diabetologia|May 31, 2020
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesityAnastasia Kalinovich, Nodi Dehvari, Alice Åslund, et al.Molecular Metabolism|May 25, 2024
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitisEmanuela Talamonti, Jelena Davegardh, Anastasia Kalinovich, et al.Cell|June 24, 2025
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesityAikaterini Motso, Benjamin Pelcman, Anastasia Kalinovich, et al.Pageof 1